Form 4: Clorox Director Breber Reports Stock, DSU Holdings

Sentiment:

Insider Transaction Report


Clorox Director Pierre R Breber reported changes in his beneficial ownership, including indirect common stock holdings and deferred stock units acquired through dividend reinvestment and director fees.

Summary

  • Pierre R Breber, a Director of The Clorox Company (CLX), filed a Form 4 statement of changes in beneficial ownership.
  • Breber reported indirect beneficial ownership of 9,000 shares of Common Stock through a family trust.
  • Acquired 5.2141 Deferred Stock Units (DSUs) on August 29, 2025, through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
  • Acquired an additional 263.5848 DSUs on September 30, 2025, in lieu of quarterly director's fees.
  • The Deferred Stock Units are designed to be settled 100% in Clorox common stock upon Breber's retirement or other termination of service as a Director.
  • Following these transactions, Breber's beneficial ownership of Deferred Stock Units increased to 765.8247 units.

Sentiment

Score: 7

Explanation: The filing indicates a director's continued accumulation of equity through compensation, which is generally a positive signal of alignment with shareholder interests and confidence in the company's long-term prospects.

Positives

  • Director Pierre R Breber increased his beneficial ownership of Deferred Stock Units, indicating continued alignment with shareholder interests.
  • Acquisition of DSUs through dividend reinvestment and in lieu of director fees demonstrates a commitment to long-term equity participation in the company.

Future Outlook

Deferred Stock Units will be settled 100% in Clorox common stock in connection with the reporting person's retirement or other termination of service as a Director.

Management Comments

  • Deferred Stock Units were acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
  • Deferred Stock Units were received in lieu of receipt of quarterly director's fees.
  • The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

Industry Context

This filing is specific to insider ownership changes at The Clorox Company and does not directly relate to broader industry trends or competitors. It reflects an individual director's equity compensation and investment decisions, which are common practices across various industries to align management incentives with shareholder interests.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation PolicyThe Independent Directors' Deferred Compensation Plan facilitates the acquisition of Deferred Stock Units by directors through dividend reinvestment and in lieu of cash fees, aligning director compensation with equity performance.NAEnhances corporate governance by linking director incentives directly to long-term shareholder value and promoting equity ownership among independent directors.

Related Party Transactions

  • Indirect beneficial ownership of 9,000 shares of Common Stock through a family trust.

Stakeholder Impact

  • Shareholders: Increased director equity ownership aligns management incentives with shareholder interests, potentially fostering long-term value creation.

Next Steps

  • Settlement of Deferred Stock Units in Clorox common stock upon the reporting person's retirement or termination of service as a Director.

Key Dates

DateDescription
08/29/2025Acquisition of 5.2141 Deferred Stock Units through dividend reinvestment.
09/30/2025Date of earliest transaction reported in the filing, also the date of acquisition of 263.5848 Deferred Stock Units in lieu of quarterly director's fees.
10/02/2025Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

The filing indicates a director's continued accumulation of equity through compensation and indirect ownership, which is generally a positive signal of alignment with shareholder interests. However, it does not present new fundamental information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

CLX, Clorox, Form 4, Insider Transaction, Director Ownership, Deferred Stock Units, Equity Compensation, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.